Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients

Clinical trial NCT03053167 · UNKNOWN

Trial details

NCT number: NCT03053167
Sponsor: China Medical University, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

ColoRectal Cancer

Start date: 2016-12-01
Primary completion: 2019-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.